Skip to main content

Table 1 Baseline characteristics

From: Cardiovascular magnetic resonance can detect occult anthracycline cardiotoxicity in adolescents and young adults cancer survivors with normal ejection fraction

CHARACTERISTICS

PATIENTS

CONTROLS

p

Age, years

18 ± 2 [12-21]

19 ± 3 [12-24]

0.109

Gender, n

11 males; 9 females

12 males; 8 females

0.749

LV ejection fraction [LVEF (%)]

59 ± 3.5

61 ± 4.2

0.057

LV end-diastolic volume indexed [LVEDVi (mL/m2)]

85 ± 16.5

85 ± 14.1

0.975

LV end-systolic volume [LVESVi (mL/m2)]

35 ± 9.5

35 ± 9.1

0.946

Global circumferential strain (GCs)

-14.0 ± 3.6

-16.4 ± 3.5

0.041

Global radial strain (GRs)

17.2 ± 6.4

30.7 ± 6.9

<0.001

Global circumferential strain rate [GCSr (syst)]

-1.25 ± 0.26

-1.58 ± 0.41

0.005

Global radial strain rate peak systole [GCRSr (syst)]

0.86 ± 0.21

2.44 ± 0.5

<0.001

Global circumferential strain rate early diastole [GCSr (diast)]

1.49 ± 0.41

1.85 ± 0.52

0.022

Global radial strain rate early diastole [GRSr (diast)]

-1.61 ± 0.38

-2.21 ± 0.61

0.001

Native T1 (mid septum, ms)

1004 ± 70.6

966 ± 30.6

0.035

LA ejection fraction total (%)

66.9 ± 8.3

67.9 ± 7.8

0.692

LA conduit function (%)

41.2 ± 15.1

41.5 ± 10.6

0.928

LA booster pump function (%)

42.3 ± 9.1

44.5 ± 10.8

0.682

LA total strain (εs)

30.6 ± 8.6

30.7 ± 7.4

0.967

LA passive strain (εe)

24.1 ± 6.4

23.3 ± 5.2

0.638

LA active strain (εa)

6.5 ± 3.5

7.5 ± 3.6

0.400

LA peak positive strain rate (SRs)

1.2 ± 0.3

1.3 ± 0.4

0.430

LA peak early negative strain rate (SRe)

-1.7 ± 0.4

1.7 ± 0.4

0.941

LA peak late negative strain rate (SRa)

-0.9 ± 0.3

-1.0 ± 0.3

0.148

Pulse wave velocity [PWV (m/s)]

4.605 ± 0.51

3.742 ± 0.23

0.019